Stem cell-based medicinal products - Scientific guideline
HumanAdvanced therapiesScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document covers specific aspects related to stem cell-based medicinal products for marketing authorisation application. It is relevant to all medicinal products using stem cells as starting material.
Keywords: Advanced therapy medicinal products, embryonic stem cells, induced pluripotent stem cells, adult stem cells, somatic stem cells, marketing authorisation application, quality, non-clinical, clinical considerations